Patent details

Basic Information

Publication number:

EP3212794

PCT Application Number:

US2015057717

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157950742

PCT Publication Number:

WO2016069694

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

POLYNUCLEOTIDE AGENTS TARGETING SERPINC1 (AT3) AND METHODS OF USE THEREOF

French Title of Invention:

AGENTS POLYNUCLÉOTIDIQUES CIBLANT SERPINC 1 (AT3) ET LEURS MÉTHODES D'UTILISATION

German Title of Invention:

POLYNUKLEOTIDWIRKSTOFFE MIT ABZIELUNG AUF SERPINC1 (AT3) UND VERFAHREN ZUR VERWENDUNG DAVON

SPC Number:

Dates

Filing date:

28/10/2015

Grant date:

07/04/2021

EP Publication Date:

06/09/2017

PCT Publication Date:

06/05/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/04/2021

EP B1 Publication Date:

07/04/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/10/2021

Expiration date:

28/10/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/03/2021

 

 

Name:

Genzyme Corporation

Address:

50 Binney Street, Cambridge, MA 02142, United States (US)

Inventor

Name:

HINKLE, Gregory

Address:

United States (US)

Priority

Priority Number:

201462072686 P

Priority Date:

30/10/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/7088; C07H 21/02; C12N 15/113;

Publication

European Patent Bulletin

Issue number:

202114

Publication date:

07/04/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages